SQL
Closed
Seqll Inc
4.
-1 (-22.22%)
Last Update: 12 Jan 2024 17:30:00
Yesterday: 4.5
Day's Range: 4. - 4.99
Send
sign up or login to leave a comment!
When Written:
0.4
SeqLL Inc is a biotechnology company that specializes in developing advanced sequencing technologies and solutions for the life sciences industry. The company was founded in 2013 and is headquartered in Woburn, Massachusetts.
SeqLL's core technology is based on a proprietary sequencing platform called "Long-Read Sequencing by Ligation" (LRS), which allows for the accurate and efficient sequencing of long DNA fragments. This technology has a wide range of applications, including genomics, transcriptomics, epigenomics, and metagenomics.
SeqLL offers a range of products and services based on its LRS technology, including sequencing instruments, reagents, and software solutions. The company also provides sequencing services to academic and industry researchers.
SeqLL has partnerships with several leading biotechnology and life sciences companies, including Illumina, Thermo Fisher Scientific, and Qiagen. The company has received funding from several venture capital firms, including Northpond Ventures and 5AM Ventures.
SeqLL's mission is to enable researchers to unlock the full potential of genomics by providing innovative sequencing solutions that are accurate, reliable, and cost-effective.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
SeqLL's core technology is based on a proprietary sequencing platform called "Long-Read Sequencing by Ligation" (LRS), which allows for the accurate and efficient sequencing of long DNA fragments. This technology has a wide range of applications, including genomics, transcriptomics, epigenomics, and metagenomics.
SeqLL offers a range of products and services based on its LRS technology, including sequencing instruments, reagents, and software solutions. The company also provides sequencing services to academic and industry researchers.
SeqLL has partnerships with several leading biotechnology and life sciences companies, including Illumina, Thermo Fisher Scientific, and Qiagen. The company has received funding from several venture capital firms, including Northpond Ventures and 5AM Ventures.
SeqLL's mission is to enable researchers to unlock the full potential of genomics by providing innovative sequencing solutions that are accurate, reliable, and cost-effective.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!